Skip to content

The incidence of hand ischaemia following different techniques for formation of elbow arteriovenous fistula

Randomised controlled trial comparing incidence of hand ischaemia following creation of either conventional brachiocephalic fistula or proximal ulnar/radial-cephalic fistula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN86060133
Enrollment
70
Registered
2010-05-04
Start date
2010-06-01
Completion date
Unknown
Last updated
2017-12-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End stage renal failure for permanent dialysis Urological and Genital Diseases Chronic renal failure

Interventions

The patients recruited for the trial would be randomised to have either conventional branchiocephalic fistula formation or fistula formation using proximal radial or ulnar artery. The patients suitabl

Sponsors

Cambridge University Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 17 to 90 years, either sex 2. Suitable for elbow autogenous arteriovenous (AV) fistula as primary or secondary access for haemodialysis

Exclusion criteria

Exclusion criteria: Patients unable to give consent

Design outcomes

Primary

MeasureTime frame
Presence of dialysis access-associated steal syndrome: 1. Digital pressure measurement 2. Symptoms: cold hand, pain, finger sensibility, strength, cramps 3. Signs: capillary refill time, ulcers, gangrenes 4. Requirement for intervention, surgical revision or ligation Measured at post-operative vascular assess clinic 2 to 3 weeks after the operation or at any timepoint when patients develop ischaemic symptoms up to 12 months follow-up.

Secondary

MeasureTime frame
1. Primary (unassisted) patency rate 2. Secondary (assisted) patency rate 3. Complications: haemorrhage, wound infection, stenosis, thrombosis, aneurysm Assessed at follow up clinic at monthly interval for the first 3 months and then 3-monthly thereafter.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026